Bill Sponsor
New York Assembly Bill 1707
Session 2023-2024
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
Became Law
Became Law
Signed by Governor on Dec 22, 2023
First Action
Jan 18, 2023
Latest Action
Dec 22, 2023
Origin Chamber
Assembly
Type
Bill
Bill Number
1707
State
New York
Session
2023-2024
Sponsorship by Party
Assembly Votes (1)
Senate Votes (1)
checkPassed on June 6, 2023
Motion Text
Assembly Vote
Assembly Roll Call Votes
Summary
Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
Actions (18)
12/22/2023
Assembly
SIGNED CHAP.738
12/12/2023
Assembly
DELIVERED TO GOVERNOR
06/06/2023
Senate
RETURNED TO ASSEMBLY
06/06/2023
Senate
PASSED SENATE
06/06/2023
Senate
3RD READING CAL.75
06/06/2023
Senate
SUBSTITUTED FOR S599A
06/06/2023
Senate
REFERRED TO RULES
06/06/2023
Assembly
DELIVERED TO SENATE
06/06/2023
Assembly
PASSED ASSEMBLY
05/30/2023
Assembly
AMENDED ON THIRD READING 1707A
05/30/2023
Assembly
RESTORED TO THIRD READING
05/30/2023
Assembly
SUBSTITUTION RECONSIDERED
05/15/2023
Assembly
SUBSTITUTED BY S599
05/11/2023
Assembly
ADVANCED TO THIRD READING CAL.196
05/09/2023
Assembly
REPORTED
04/26/2023
Assembly
REPORTED REFERRED TO CODES
02/08/2023
Assembly
REFERENCE CHANGED TO INSURANCE
01/18/2023
Assembly
REFERRED TO HEALTH